[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"lrg-levels\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:lrg-levels":35},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":4,"briefSummary":20,"conditions":21,"keywords":4,"overallStatus":23,"whyStopped":4,"lastUpdateSubmitDate":24,"lastUpdatePostDateStruct":25,"startDateStruct":28,"completionDateStruct":30,"leadSponsor":32,"locationsCount":5},"100403635",false,"NCT04535882","Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD","Association Between Serum Leucine-rich Alpha-2 Glycoprotein Levels and Endoscopic Activity of Possible Ulcerative Colitis or Crohn's Disease Colitis","Inclusion Criteria:\n\n* Patients whom possible UC or Crohn disease was suspected\n\nExclusion Criteria:\n\n* other autoimmune diseases\n* acute or chronic renal failure\n* chronic heart diseases\n* liver cirrhosis\n* cancer\n* acute or chronic infections\n* ischemic colitis\n* infectious colitis","ALL",{"count":17,"type":18},300,"ESTIMATED","OBSERVATIONAL","We attempt to examine the association between serum leucine-rich alpha-2 glycoprotein (LRG) levels and endoscopic activity in patients with possible ulcerative colitis (UC) or Crohn's disease (CD) to determine whether LRG was a predicting marker for UC or CD.",[22],"LRG Levels","RECRUITING","2026-05-09",{"date":26,"type":27},"2026-05-13","ACTUAL",{"date":29,"type":27},"2020-10-01",{"date":31,"type":18},"2026-12-31",{"name":33,"class":34},"Showa Inan General Hospital","OTHER",""]